Long-Term Effects of Caffeine Therapy for Apnea of Prematurity

Caffeine therapy for apnea of prematurity improves the rate of survival without neurodevelopmental disability at 18 to 21 months in infants with very low birth weight. (ClinicalTrials.gov number, NCT00182312 ClinicalTrials.gov.).